Validation of Elekta iViewGT A-Si EPID Model for Pre-Treatment Dose Verification of IMRT Fields


A Monte Carlo model of Elekta iViewGT amorphous silicon electronic portal imaging device (a-Si EPID) has been validated for pre-treatment dose verification of clinical IMRT treatment plans. The simulation employed BEAMnrc and DOSXYZnrc MC codes to predict the dose deposition in the iViewGT a-Si EPID model. The predicted dose distributions were compared to the measured dose distributions obtained from the experiment. The measured EPID images were obtained by delivering a photon beam from Elekta Precise linac to the Elekta iViewGT a-Si EPID. The a-Si EPID was used as non-transit dosimetry with no extra build-up material placed above the EPID detector. The EPID images were acquired using frame-averaging acquisition and were processed using in-house application software. The agreement between the predicted and measured dose distribution was analyzed using the gamma analysis technique with the acceptance criteria of 3%, 3 mm. The results show that the predicted dose distributions of four clinical IMRT treatment plans have a good agreement with the measurement. Three prostate IMRT plans have the average gamma pass rate more than 95% and a spinal IMRT plan has the average gamma pass rate of 94.27%. Overall, Monte Carlo simulation shows a suitability to be implemented for pre-treatment dose verification, promising a better accuracy than the existing algorithms in Treatment Planning System (TPS).

  • Abstract
  • Key Words
  • 1. Introduction
  • 2. Materials and Methods
  • 3. Results and Discussion
  • 5. Conclusion
  • 6. References

Related Content

Customize your page view by dragging and repositioning the boxes below.

Related Journal Articles
Related eBook Content
Topic Collections

Sorry! You do not have access to this content. For assistance or to subscribe, please contact us:

  • TELEPHONE: 1-800-843-2763 (Toll-free in the USA)
  • EMAIL: asmedigitalcollection@asme.org
Sign In